Epilepsy Foundation of Greater Los Angeles Awards University of California, San Francisco with a $50,000 Care and Cure Fellowship Grant

March 30, 2012

A portion of the grant funding raised at the local Foundation’s annual Care and Cure Benefit will support UCSF postdoctoral fellow Jiadong Chen´s clinical training and research to aid in the effort to care and cure pediatric epilepsy.

Los Angeles, CA (PRWEB) March 30, 2012

The Epilepsy Foundation of Greater Los Angeles awarded a $50,000 “Care and Cure” grant to the University of California, San Francisco to support the postdoctoral training and work of Jiadong Chen, Ph.D.

The Care and Cure Pediatric Epilepsy Fellowship grants support exemplary physicians and scientists with a demonstrable interest in pursuing clinical or research training in the field of pediatric epilepsy. The Fellowship was established by the Epilepsy Foundation of Greater Los Angeles as a way to combat the critical need for more experts who are able to evaluate, treat, or perform research that will profoundly affect the lives of children with epilepsy.

Trained as an electrophysiologist and hoping to explore stem cell-derived inhibitory interneurons as a way to treat medically-intractable epilepsy during his training at UCSF’s Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Chen is one of ten awardees at four different healthcare institutions who have received funds or commitment of funds since the inception of Care and Cure in 2005.

“There is an overwhelming need for more doctors to specialize in the care and cure of pediatric epilepsy. Sadly, however, there is a disproportionately short supply of funding; doctors and scientists who want to help cure epilepsy can´t do so because a limited funding allocated to the pediatric epilepsies. Our Care and Cure Initiatives help support the training and work of more specialists so that eventually all children with epilepsy get the care they urgently need, today, and can have hope for cures in the future,” explained Susan Pietsch Escueta, Executive Director of the Epilepsy Foundation of Greater Los Angeles.

The local Foundation hosts an annual Care and Cure Benefit to raise funds for grants for fellowships and for specialty dietary therapy programs, and to support epilepsy education and advocacy throughout California.

“It can take several months for a child experiencing seizures to be seen by an epilepsy specialist. As seizures can have devastating effects on the developing brain, including mental retardation, functional limitations, and learning delays and may even result in early death, any delay in treatment is unacceptable,” said Mark Borman and Andrew Gumpert in a joint statement as co-chairs of the Care and Cure Benefit and as Trustees of the local Foundation.

Please join the Epilepsy Foundation of Greater Los Angeles on June 5th, 2012 at the Beverly Wilshire Hotel for this year´s Care and Cure Benefit, as we honor American film producer Lorenzo di Bonaventura. Visit http://www.CareAndCure.org for more event information.



Without warning, seizures can happen to anyone at any age. When a person has two or more unprovoked seizures, they have epilepsy. Seizures do not all look the same and, according to the International League Against Epilepsy, there are currently more than 25 different recognized epilepsy syndromes affecting almost 3 million people in the U.S. and about 60 million people worldwide. Someone is diagnosed with epilepsy every four minutes and, this year alone, another 200,000 people in our country will be diagnosed. To date, there are no known cures.


Established in 1957 as a 501(c)3 charitable organization, the Epilepsy Foundation of Greater Los Angeles is leading the fight to END EPILEPSY® and the burden of seizures. Our areas of focus are care, advocacy, research and education. We dedicate the CARE AND CURE Benefit to thousands of children with epilepsy who urgently need specialty care while they hope for cures. http://www.END-EPILEPSY.org

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9339332.htm

Source: prweb

comments powered by Disqus